Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. - Ellis,CN.; Varani,J.; Fisher,GJ.; Zeigler,ME.; Pershadsingh,HA.; Benson,SC.; Chi,Y.; Kurtz,TW. (Arch Dermatol, 2000)